Media Summary: Cardinal Health Advanced Therapy Solutions enable breakthroughs in Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ... Hear from Edward Stevens, Manager of Capital Products, GSK, as he gives an overview of the design approach used to establish ...

Planning For Cell Gene Therapy Commercialization - Detailed Analysis & Overview

Cardinal Health Advanced Therapy Solutions enable breakthroughs in Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ... Hear from Edward Stevens, Manager of Capital Products, GSK, as he gives an overview of the design approach used to establish ... Moderator: Joshua Schimmer, M.D., Managing Director and Senior Research Analyst, Piper Jaffray Speakers: Faraz Ali, Chief ... This webinar will explore the critical steps required to successfully bring Chair: Matthew Durdy, Chief Business Officer,

Our experts reveal the first of three steps to industrialize Dr Qasim Rafiq presented a webinar on our new, one-year programme that opened for entry in September 2020 along with ... This panel from the 2024 CGT Summit hosted by Charles River Laboratories brings together experts from Moonlight Bio, ... Session Chair: Phil Vanek, General Manager, Fluor subject matter expert Abhirath S. Parikh, Ph.D. discusses the advances and intricacies of the

Photo Gallery

Planning for Cell & Gene Therapy Commercialization
Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy
Enabling breakthroughs in cell and gene therapy development & commercialization
Commercialization Learnings with Novartis Gene Therapies' President Chris Fox
Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies
Overview of Planning, Building and Operating Cell and Gene Therapy Facilities:  Edward Stevens
Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop
Panel: Gene Therapy: Commercialization Readiness and Market Access Challenges
Commercialization Strategies for Cell and Gene Therapies
Panel: Gene Therapy Commercialization
Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’
Three challenges to commercializing cell therapy
Sponsored
Sponsored
View Detailed Profile
Planning for Cell & Gene Therapy Commercialization

Planning for Cell & Gene Therapy Commercialization

Planning for Cell

Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy

Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy

In the dynamic environment of the

Sponsored
Enabling breakthroughs in cell and gene therapy development & commercialization

Enabling breakthroughs in cell and gene therapy development & commercialization

Cardinal Health Advanced Therapy Solutions enable breakthroughs in

Commercialization Learnings with Novartis Gene Therapies' President Chris Fox

Commercialization Learnings with Novartis Gene Therapies' President Chris Fox

With 20+

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The ...

Sponsored
Overview of Planning, Building and Operating Cell and Gene Therapy Facilities:  Edward Stevens

Overview of Planning, Building and Operating Cell and Gene Therapy Facilities: Edward Stevens

Hear from Edward Stevens, Manager of Capital Products, GSK, as he gives an overview of the design approach used to establish ...

Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop

Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop

READINESS STRATEGIES FOR

Panel: Gene Therapy: Commercialization Readiness and Market Access Challenges

Panel: Gene Therapy: Commercialization Readiness and Market Access Challenges

Moderator: Joshua Schimmer, M.D., Managing Director and Senior Research Analyst, Piper Jaffray Speakers: Faraz Ali, Chief ...

Commercialization Strategies for Cell and Gene Therapies

Commercialization Strategies for Cell and Gene Therapies

This webinar will explore the critical steps required to successfully bring

Panel: Gene Therapy Commercialization

Panel: Gene Therapy Commercialization

Chair: Matthew Durdy, Chief Business Officer,

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’

Our experts reveal the first of three steps to industrialize

Three challenges to commercializing cell therapy

Three challenges to commercializing cell therapy

Watch Christopher live at the

Plenary Session: Cell Therapy Commercialization Today and Preparing for the Future

Plenary Session: Cell Therapy Commercialization Today and Preparing for the Future

Over the past several years, the

Panel: Gene Therapy: Commercializing a Therapeutic Product

Panel: Gene Therapy: Commercializing a Therapeutic Product

GENE THERAPY

Manufacturing & Commercialisation of Cell and Gene Therapy MSc Webinar 18.01.21 with Dr Qasim Rafiq

Manufacturing & Commercialisation of Cell and Gene Therapy MSc Webinar 18.01.21 with Dr Qasim Rafiq

Dr Qasim Rafiq presented a webinar on our new, one-year programme that opened for entry in September 2020 along with ...

Viral Vector Gene Therapy: From Discovery to Commercialization

Viral Vector Gene Therapy: From Discovery to Commercialization

This panel from the 2024 CGT Summit hosted by Charles River Laboratories brings together experts from Moonlight Bio, ...

Cell Therapy Commercialization in Oncology

Cell Therapy Commercialization in Oncology

Session Chair: Phil Vanek, General Manager,

Site Design Considerations for Cell and Gene Therapy Commercial Facilities

Site Design Considerations for Cell and Gene Therapy Commercial Facilities

Fluor subject matter expert Abhirath S. Parikh, Ph.D. discusses the advances and intricacies of the

Economic and Commercial Bases for Pricing of Genetic Therapies - Eric Auger

Economic and Commercial Bases for Pricing of Genetic Therapies - Eric Auger

Economic and

Cell Therapy Commercialization in Oncology

Cell Therapy Commercialization in Oncology

Session Chair: Phil Vanek, General Manager,